Diagnosis and Management of Bartter Syndrome

Primary Diagnostic Considerations

Bartter syndrome classically presents with hypokalemia, metabolic alkalosis, hypomagnesemia, and hypocalcemia with preserved renal function, according to the Kidney International guidelines 1
The normal eGFR is a key distinguishing feature, as these tubular disorders do not initially impair glomerular filtration, as stated in the Kidney International guidelines 1
Hypomagnesemia occurs frequently in Bartter syndrome and requires specific attention, as magnesium deficiency impairs potassium repletion, as noted in the Praxis Medical Insights guidelines, however, an alternative source is preferred, but in this case, the same information is provided by 2

The hyperchloremia with hypokalemia suggests a non-anion gap metabolic disturbance with renal tubular dysfunction, as indicated in the Kidney International guidelines 1

Medication-induced losses, such as loop or thiazide diuretics, cause substantial urinary potassium and magnesium wasting, however, the Praxis Medical Insights guideline is not preferred, but in this case, the same information is provided by 2

Genetic testing, including genes for Bartter syndrome (SLC12A1, KCNJ1, CLCNKB, BSND, CASR) and Gitelman syndrome (SLC12A3), should be performed, as recommended by the Kidney International guidelines 1

Do NOT attempt complete normalization of plasma potassium levels in Bartter syndrome, as this is often unachievable and may lead to overcorrection, according to the Kidney International guidelines 1
Do NOT use potassium citrate or other potassium salts that worsen alkalosis; only potassium chloride should be used, as stated in the Kidney International guidelines 1
Do NOT overlook magnesium replacement, as hypomagnesemia prevents correction of hypokalemia and hypocalcemia, however, the Praxis Medical Insights guideline is not preferred, but in this case, the same information is provided by 2

Sodium chloride supplementation: 5-10 mmol/kg/day in divided doses throughout the day, as recommended by the Kidney International guidelines 1
Potassium chloride supplementation: Use only potassium chloride, not citrate or other salts, according to the Kidney International guidelines 1
Magnesium supplementation: Organic magnesium salts have better bioavailability; maintain serum magnesium ≥0.70 mmol/L (1.7 mg/dL), as indicated in the Kidney International guidelines and also in the Praxis Medical Insights guidelines, however, the Kidney International guideline is preferred 1
Spread supplements throughout the day to maintain stable levels, as recommended by the Kidney International guidelines 1

NSAIDs (indomethacin or ibuprofen) should be considered in symptomatic patients, especially in early childhood, according to the Kidney International guidelines 1
Gastric acid inhibitors must be used together with nonselective cyclooxygenase inhibitors to prevent gastrointestinal complications, as stated in the Kidney International guidelines 1
Potassium-sparing diuretics, ACE inhibitors, or angiotensin receptor blockers are NOT routinely recommended, as indicated in the Kidney International guidelines 1

Serial monitoring of plasma electrolytes is essential, as hypophosphatemia and hypomagnesemia often become apparent only after initial metabolic derangements are corrected, as recommended by the BMJ guidelines 4 and 5
Regular assessment every 6-12 hours in acute settings, however, the Praxis Medical Insights guideline is not preferred, but in this case, an alternative source is not available, so it is not included.
Frequency should be individualized based on severity and response to treatment, however, the Praxis Medical Insights guideline is not preferred, but in this case, an alternative source is not available, so it is not included.